We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,295 hedge funds and large institutions have $45.6B invested in Edwards Lifesciences in 2024 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 463 increasing their positions, 465 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 122 | Existing positions closed: 90

7% more funds holding in top 10

Funds holding in top 10: 14 → 15 (+1)

1% more funds holding

Funds holding: 1,279 → 1,295 (+16)

0.67% more ownership

Funds ownership: 81.25% → 81.93% (+0.67%)

0% less repeat investments, than reductions

Existing positions increased: 463 | Existing positions reduced: 465

2% less capital invested

Capital invested by funds: $46.6B → $45.6B (-$1.03B)

7% less call options, than puts

Call options by funds: $276M | Put options by funds: $297M

Holders
1,295
Holders Change
+16
Holders Change %
+1.25%
% of All Funds
18.7%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.22%
New
122
Increased
463
Reduced
465
Closed
90
Calls
$276M
Puts
$297M
Net Calls
-$21M
Net Calls Change
-$59.1M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$348M
2
SFFS
Stonehage Fleming Financial Services
Jersey
+$204M
3
UBS AM
UBS AM
Illinois
+$137M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$122M
5
Swedbank
Swedbank
Sweden
+$109M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$224M
2
Citadel Advisors
Citadel Advisors
Florida
-$179M
3
BlackRock
BlackRock
New York
-$128M
4
JP Morgan Chase
JP Morgan Chase
New York
-$81.7M
5
State Street
State Street
Massachusetts
-$67.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1326
Boothbay Fund Management
New York
– -$1.14M -11,974 Closed
BL
1327
Balentine LLC
Georgia
– -$1.12M -11,770 Closed
NL
1328
NWAM LLC
Washington
– -$908K -10,580 Closed
MS
1329
Maven Securities
Jersey
– -$886K -10,000 Closed
HWM
1330
Hohimer Wealth Management
Washington
– -$692K -7,246 Closed
UM
1331
Ulysses Management
New York
– -$669K -7,000 Closed
CG
1332
Caprock Group
Idaho
– -$635K -6,640 Closed
AF
1333
Ally Financial
Michigan
– -$573K -6,000 Closed
HIC
1334
Hartline Investment Corp
Illinois
– -$510K -5,340 Closed
AWA
1335
Alta Wealth Advisors
Massachusetts
– -$487K -5,094 Closed
DC
1336
Diametric Capital
Massachusetts
– -$460K -4,811 Closed
Qube Research & Technologies (QRT)
1337
Qube Research & Technologies (QRT)
United Kingdom
– -$458K -4,793 Closed
AIM
1338
Aigen Investment Management
New York
– -$433K -4,532 Closed
YC
1339
Yarbrough Capital
Tennessee
– -$361K -3,776 Closed
LB
1340
Legacy Bridge
Iowa
– -$357K -3,741 Closed
Wolverine Trading
1341
Wolverine Trading
Illinois
– -$314K -3,549 Closed
MA
1342
Mutual Advisors
Nebraska
– -$325K -3,402 Closed
MJP
1343
Michael J. Puzo
– -$320K -3,350 Closed
AAS
1344
Ameritas Advisory Services
Nebraska
– -$311K -3,269 Closed
DWA
1345
Delap Wealth Advisory
Oregon
– -$305K -3,196 Closed
DS
1346
DRW Securities
Illinois
– -$279K -3,146 Closed
MA
1347
Mezzasalma Advisors
New Jersey
– -$297K -3,105 Closed
FFP
1348
FourThought Financial Partners
Florida
– -$270K -2,827 Closed
MPAM
1349
Murphy Pohlad Asset Management
Minnesota
– -$255K -2,664 Closed
DFCM
1350
Dark Forest Capital Management
Puerto Rico
– -$252K -2,639 Closed
52 53
54
55 56

EW Hedge Fund Activity: Q2 2024 in Review

1,295 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2024, worth a combined $45.6B — down 2.2% from $46.6B a quarter earlier.

Buyers outnumbered sellers: 122 funds opened new EW positions and 90 closed out — a net gain of 32 holders — while 463 added to existing stakes and 465 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $348M. The largest seller was Point72 Asset Management, cutting an estimated $224M.

  • 1,295 institutional investors held Edwards Lifesciences (EW) as of Q2 2024, up from 1,279 in Q1 2024.
  • Funds reported $45.6B of Edwards Lifesciences stock for Q2 2024, down 2.2% quarter-over-quarter.
  • 122 funds opened new Edwards Lifesciences positions in Q2 2024 and 90 closed out, a net change of +32 holders.
  • The largest Edwards Lifesciences buyer in Q2 2024 was AllianceBernstein, an estimated $348M added.
  • The largest Edwards Lifesciences seller in Q2 2024 was Point72 Asset Management, an estimated $224M sold.

Based on aggregated 13F filings for Q2 2024.